Updated Jul 16, 2026
TZOUMAKAS KIMBERLY JO has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Kimberly Jo Tzoumakas serves as a director of Oncology Institute, Inc. based on the most recent SEC filing dated 2026-07-09. The available SEC context provides limited public information about her professional background beyond her board involvement. As a director, she is part of the company’s governance and oversight framework.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | TOI | Oncology Institute, Inc. | A — Grant or award | 17.2K | $0.00 |
Kimberly Jo Tzoumakas serves as a director of Oncology Institute, Inc. based on the most recent SEC filing dated 2026-07-09. The available SEC context provides limited public information about her professional background beyond her board involvement. As a director, she is part of the company’s governance and oversight framework.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live TZOUMAKAS KIMBERLY JO profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.